-
Bestatin: From Zinc Binding to Assay Design
2026-09-27
Bestatin (Ubenimex) is more than a broad aminopeptidase probe: its crystallographic binding mode helps explain how to design and interpret inhibition experiments. This guide connects enzyme structure, potency measurements, and cell-based research while distinguishing established evidence from practical recommendations.
-
Dimethyloxalylglycine (DMOG): Practical Lab Guide
2026-09-26
Dimethyloxalylglycine (DMOG; SKU A4506) is a cell-permeable PHD inhibitor for experimentally stabilizing HIF and investigating hypoxia signaling without changing ambient oxygen. Use it for controlled research assays, with dose and exposure optimized for the model; it is not intended for diagnostic, therapeutic, or clinical use.
-
Dimethyloxalylglycine (DMOG): Research Workflow Guide
2026-09-25
Dimethyloxalylglycine (DMOG) is used in controlled experiments to inhibit PHD enzymes and stabilize HIF-1α, supporting studies of oxygen sensing, hypoxia signaling, and selected inflammation responses. It is a research reagent—not a substitute for low-oxygen culture conditions in every experiment and not for diagnostic, therapeutic, or clinical use.
-
Thymosin-β4 Drives Angiogenesis in Limb Ischemia
2026-09-25
This study links thymosin-β4 (Tβ4) to endothelial angiogenic behavior and changes in Notch/NF-κB pathway markers in cell and critical limb ischemia models. Pharmacological inhibition supports involvement of both pathways, while the results remain preclinical and do not establish that either pathway is a direct molecular target of Tβ4.
-
Danazol Models: Interpreting Puberty-Axis Evidence
2026-09-24
Danazol is more than a steroidogenesis tool: its mixed endocrine actions make careful endpoint selection essential in puberty research. This article interprets a recent rat study through model design, readout limits, and practical assay decisions.
-
Mianserin HCl: Receptor and Cyclodextrin Workflows
2026-09-24
Use Mianserin HCl to investigate 5-HT2 receptor signaling and noradrenergic pharmacology, then test how cyclodextrin complexation changes assay exposure and cell toxicity. The key practical finding is that methylated β-cyclodextrin increased, rather than reduced, mianserin-associated cytotoxicity in the reported cell model.
-
Tioconazole for Antifungal Research
2026-09-23
Tioconazole is an antifungal medication used in research on fungal growth and ergosterol biosynthesis. Its product information describes fungal cytochrome P450 inhibition and reports formulation, solubility, purity, and storage specifications; these details support assay planning but do not replace experimental controls or establish clinical use.
-
Fenofibrate, PPARα–YAP Signaling, and Aging Liver
2026-09-23
The reference study shows that Fenofibrate produces comparable liver enlargement and PPARα–YAP pathway activation in adult and aging mouse models. Its use of several aging paradigms separates age-related regenerative decline from the preserved hepatic response to PPARα activation, while also clarifying how hepatocyte hypertrophy and proliferation contribute to the phenotype.
-
Paroxetine Mesylate: From SERT to Cancer Assays
2026-09-22
Paroxetine Mesylate is a Selective serotonin reuptake inhibitor whose research value extends from SERT pharmacology to MET–ERBB3 signaling in colorectal cancer models. This article explains how to interpret its concentration-dependent biology, salt-form identity, and multi-endpoint assay evidence without overextending preclinical findings.
-
Human PSC Teratomas Reveal Skeletal Myogenic Lineage
2026-09-22
Pappas and colleagues show that human pluripotent stem cell-derived teratomas generate multiple skeletal myogenic progenitor states that parallel stages of embryonic muscle development. Single-cell transcriptomics and surface-marker validation identify ERBB3 and CD82 as practical handles for enriching this lineage, providing a foundation for studying human muscle development and regenerative cell sourcing.
-
Abiraterone Acetate: CYP17 Inhibitor Research Guide
2026-09-21
Abiraterone acetate is a CYP17 inhibitor used to study androgen biosynthesis and prostate cancer biology. Its reported nanomolar potency, formulation constraints, and mixed performance in patient-derived spheroids define a research framework rather than a clinical treatment recommendation.
-
BMS-345541 in Notch/NF-κB Limb Ischemia Research
2026-09-21
The reference study shows that thymosin-β4 promotes endothelial activity and post-ischemic angiogenesis in critical limb ischemia through coordinated Notch/NF-κB signaling. Its use of DAPT and BMS pathway inhibition links molecular signaling changes with cell migration, tube formation, and vascular-marker expression, while also highlighting important limits of pharmacological pathway interpretation.
-
Sumatriptan Succinate for Translational Assays
2026-09-20
Sumatriptan Succinate can do more than model migraine biology: it supports receptor-resolved studies of CGRP release, inflammatory signaling, ischemia/reperfusion injury, and drug metabolism. This workflow-oriented guide shows how to choose concentrations, controls, endpoints, and troubleshooting strategies for reproducible serotonergic signaling research.
-
Tioconazole: Causal Assays for Fungal Biology
2026-09-19
Tioconazole is an antifungal medication for dissecting ergosterol-dependent fungal phenotypes. This article presents an assay-interpretation framework inspired by energy-sensitive DNA-repair research, helping distinguish target engagement, metabolic stress, and nonspecific loss of viability.
-
Topological Stress, rDNA Lesions, and PML Compartments
2026-09-18
Urbancokova and colleagues show that persistent damage in ribosomal DNA, rather than genotoxic stress in general, is a key trigger of PML-nucleolar associations. Their combination of chemical stress, targeted I-PpoI cleavage, repair-pathway perturbation, and lesion-state imaging provides a framework for studying how nucleolar DNA damage contributes to senescence and genome instability.